Breaking News Instant updates and real-time market news.

INSY

Insys Therapeutics

$4.42

-0.25 (-5.35%)

07:37
01/22/19
01/22
07:37
01/22/19
07:37

Insys Therapeutics initiated with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Brandon Folkes started Insys Therapeutics with an Overweight rating and $9 price target. The analyst sees 2019 as a "pivotal and transformational year" for Insys with two potential filings with its spray platform along with two data readouts from its cannabinoids platform. 2019 could be the year in which investors are able to return to Insys and "appreciate the value which could be unlocked from within the company's spray and cannabinoids pipeline," Folkes tells investors in a research note.

INSY Insys Therapeutics
$4.42

-0.25 (-5.35%)

12/19/18
JANY
12/19/18
INITIATION
Target $11
JANY
Buy
Insys Therapeutics assumed with a Buy at Janney Montgomery Scott
Janney Montgomery Scott analyst Yun Zhong assumed coverage of Insys Therapeutics with a Buy rating and fair value estimate of $11, down from the firm's prior $16 estimate. Zhong said Insys is shifting focus from commercializing opioid products to developing cannabinoids and proprietary spray technology, adding that he views the heated discussion during a two-day FDA AdCom on naloxone earlier this week as a "clear sign" for an increased commercial opportunity for Insys. Zhong also believes the data from the cannabidiol programs, if positive, could unlock significant upside potential.
08/10/18
PIPR
08/10/18
NO CHANGE
Target $4
PIPR
Underweight
Insys DOJ settlement does not remove downside risk, says Piper Jaffray
Piper Jaffray analyst David Amsellem says the settlement with the Department of Justice does not mean there isn't downside risk in shares of Insys Therapeutics. For a $600M market capitalization, investors are getting a sublingual form of buprenorphine that was "roundly rejected" by an FDA panel in May, a cannabidiol product that has yet to demonstrate proof-of-concept in a well-controlled trial, a product in Syndros that has minimal sales after approximately one year of active promotion, and a declining asset in Subsys that has limited profitability, Amsellem tells investors in a research note following Insys' Q2 results. The analyst does not believe the shares are "adequately risk-adjusted." He reiterates an Underweight rating on Insys with a $4 price target.
03/09/18
PIPR
03/09/18
DOWNGRADE
Target $4
PIPR
Underweight
Insys Therapeutics downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst David Amsellem downgraded Insys Therapeutics to Underweight and cut his price target for the shares to $4 from $5. The analyst sees "no basis in reality" for the company's guidance of relatively stable total sales in 2018 versus 2017 given the nature of the opioid crisis. Further, the weak rollout of Syndros "also does not inspire confidence" in the 2018 guidance, Amsellem tells investors in a research note.

TODAY'S FREE FLY STORIES

VLKAY

Volkswagen

$0.00

(0.00%)

15:25
03/20/19
03/20
15:25
03/20/19
15:25
Periodicals
Volkswagen management not yet aligned on restructuring plans, Reuters says »

Volkswagen's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
03/20/19
03/20
15:20
03/20/19
15:20
General news
Powell on the balance sheet: »

Powell on the balance…

15:20
03/20/19
03/20
15:20
03/20/19
15:20
General news
Powell on Brexit »

Powell on Brexit: he hope…

WPM

Wheaton Precious Metals

$23.12

0.385 (1.69%)

15:19
03/20/19
03/20
15:19
03/20/19
15:19
Options
Wheaton Precious Metals options imply 6.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/20/19
03/20
15:17
03/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/20/19
03/20
15:16
03/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
03/20/19
03/20
15:15
03/20/19
15:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

AMZN

Amazon.com

$1,793.67

31.22 (1.77%)

15:11
03/20/19
03/20
15:11
03/20/19
15:11
Hot Stocks
Amazon.com announces launch of MLB.TV on Prime Video Channels »

Amazon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

UNIT

Uniti Group

$9.94

0.08 (0.81%)

15:04
03/20/19
03/20
15:04
03/20/19
15:04
Options
Uniti Group options imply 6.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVS

Novartis

$93.75

0.76 (0.82%)

15:01
03/20/19
03/20
15:01
03/20/19
15:01
Periodicals
Novartis CEO wants to move towards 'transformational innovation,' Fortune says »

Novartis CEO Vasant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.06

0.58 (0.21%)

15:00
03/20/19
03/20
15:00
03/20/19
15:00
General news
Fed chair Powell says he thinks 'deficits matter' »

Federal Reserve chairman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.06

0.58 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
03/20/19
03/20
15:00
03/20/19
15:00
General news
FX Action: USD-CAD »

FX Action: USD-CAD hit…

14:55
03/20/19
03/20
14:55
03/20/19
14:55
General news
Canada wholesale report preview »

Canada wholesale report…

14:55
03/20/19
03/20
14:55
03/20/19
14:55
General news
Fed Chairman Powell on the outlook: »

Fed Chairman Powell on…

14:55
03/20/19
03/20
14:55
03/20/19
14:55
General news
Powell on the balance of risks: »

Powell on the balance of…

BA

Boeing

$379.38

5.51 (1.47%)

, LMT

Lockheed Martin

$298.16

1.61 (0.54%)

14:52
03/20/19
03/20
14:52
03/20/19
14:52
Periodicals
Pentagon's IG investigating Shanahan over Boeing comments, Politico says »

The Pentagon's…

BA

Boeing

$379.38

5.51 (1.47%)

LMT

Lockheed Martin

$298.16

1.61 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.17

0.69 (0.24%)

14:52
03/20/19
03/20
14:52
03/20/19
14:52
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Fed chair Powell says…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.17

0.69 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$88.99

-0.11 (-0.12%)

14:50
03/20/19
03/20
14:50
03/20/19
14:50
Options
Bullish three-way spread in Celgene »

Bullish three-way spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Apr

  • 18

    May

  • 28

    May

  • 27

    Jun

  • 03

    Sep

ALXN

Alexion

$132.07

-0.87 (-0.65%)

14:49
03/20/19
03/20
14:49
03/20/19
14:49
Recommendations
Alexion analyst commentary at Piper Jaffray »

Alexion turnaround…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.24

0.76 (0.27%)

14:49
03/20/19
03/20
14:49
03/20/19
14:49
General news
Fed chair Powell says ongoing risks to outlook include Brexit, trade talks »

Federal Reserve chairman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.24

0.76 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$40.38

(0.00%)

14:49
03/20/19
03/20
14:49
03/20/19
14:49
Options
Micron options imply 11.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

TSN

Tyson Foods

$65.30

-0.48 (-0.73%)

14:48
03/20/19
03/20
14:48
03/20/19
14:48
Options
Tyson Foods call buyer gobbles another 10K lot »

Tyson Foods call buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$282.89

0.41 (0.15%)

14:46
03/20/19
03/20
14:46
03/20/19
14:46
Hot Stocks
Breaking Hot Stocks news story on S&P 500, SPDR S&P 500 ETF Trust, Wells Fargo »

Fed chair Powell says…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$282.89

0.41 (0.15%)

WFC

Wells Fargo

$50.90

-0.52 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 23

    Apr

  • 28

    May

  • 13

    Jul

  • 12

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.11

0.63 (0.22%)

14:45
03/20/19
03/20
14:45
03/20/19
14:45
General news
Fed chair Powell says slowing global growth a 'headwind' for U.S. economy »

Federal Reserve chairman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.11

0.63 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPR

Spirit AeroSystems

$91.84

0.845 (0.93%)

14:42
03/20/19
03/20
14:42
03/20/19
14:42
Hot Stocks
Spirit AeroSystems receives EU approval for Asco acquisition »

Spirit AeroSystems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.